Palo Alto Investors’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
Other funds holding GOSS
KCM
VCM
AVM
OCA
SB
SL
Palo Alto Investors's GOSS Position: Q1 2026 in Review
Palo Alto Investors sold out of Gossamer Bio (GOSS) in Q1 2026, closing a stake of 4,471,592 shares — an estimated $13.9M sold.
Palo Alto Investors first reported a position in GOSS in Q2 2020 and held it in 23 quarters. The position peaked at $22.3M in Q3 2021. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.
- Palo Alto Investors reported no remaining Gossamer Bio position as of Q1 2026 after selling out during the quarter.
- Palo Alto Investors sold 4,471,592 Gossamer Bio shares in Q1 2026, an estimated $13.9M.
- Palo Alto Investors first reported a position in Gossamer Bio in Q2 2020 and held it in 23 quarters.
- Palo Alto Investors's Gossamer Bio position peaked at $22.3M in Q3 2021.
- 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.
Based on Palo Alto Investors's 13F filing for Q1 2026, filed 15 May 2026.